JP2006316075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006316075A5 JP2006316075A5 JP2006239375A JP2006239375A JP2006316075A5 JP 2006316075 A5 JP2006316075 A5 JP 2006316075A5 JP 2006239375 A JP2006239375 A JP 2006239375A JP 2006239375 A JP2006239375 A JP 2006239375A JP 2006316075 A5 JP2006316075 A5 JP 2006316075A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- solution
- range
- concentration
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- 239000000243 solution Substances 0.000 claims 21
- 238000000034 method Methods 0.000 claims 14
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 claims 12
- 229960002292 piperacillin Drugs 0.000 claims 10
- 229960003865 tazobactam Drugs 0.000 claims 9
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 claims 9
- 239000007788 liquid Substances 0.000 claims 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 4
- 239000000872 buffer Substances 0.000 claims 4
- 239000008121 dextrose Substances 0.000 claims 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 4
- 239000001509 sodium citrate Substances 0.000 claims 4
- 230000003139 buffering effect Effects 0.000 claims 3
- NDIURPSCHWTXDC-UHFFFAOYSA-N 2-(4,5-dimethoxy-2-nitrophenyl)acetohydrazide Chemical compound COC1=CC(CC(=O)NN)=C([N+]([O-])=O)C=C1OC NDIURPSCHWTXDC-UHFFFAOYSA-N 0.000 claims 2
- 229960005264 piperacillin sodium Drugs 0.000 claims 2
- 229960000373 tazobactam sodium Drugs 0.000 claims 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 239000007979 citrate buffer Substances 0.000 claims 1
- 239000011259 mixed solution Substances 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/255,513 US6207661B1 (en) | 1999-02-22 | 1999-02-22 | Premixed formulation of piperacillin sodium and tazobactam sodium injection |
| US09/255,513 | 1999-02-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000600646A Division JP2002537335A (ja) | 1999-02-22 | 2000-01-21 | ピペラシリンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006316075A JP2006316075A (ja) | 2006-11-24 |
| JP2006316075A5 true JP2006316075A5 (cg-RX-API-DMAC7.html) | 2009-12-10 |
| JP4820244B2 JP4820244B2 (ja) | 2011-11-24 |
Family
ID=22968672
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000600646A Withdrawn JP2002537335A (ja) | 1999-02-22 | 2000-01-21 | ピペラシリンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物 |
| JP2006239375A Expired - Lifetime JP4820244B2 (ja) | 1999-02-22 | 2006-09-04 | ピペラジンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000600646A Withdrawn JP2002537335A (ja) | 1999-02-22 | 2000-01-21 | ピペラシリンナトリウムおよびタゾバクタムナトリウムの注射の予備混合処方物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6207661B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1154770B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2002537335A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE426404T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2856200A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2361392C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1108966T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60041868D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1154770T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2322790T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1154770E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000050035A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20011718A1 (it) * | 2001-08-03 | 2003-02-03 | Istituto Biochimico Italiano | Processo per la preparazione del sale sodico dell'acido-6(d-(-)-alpha-(4-etil-2,3-diosso-1-piperazinocarbonilammino)fenilacetammido)penicill |
| US6900184B2 (en) * | 2003-04-14 | 2005-05-31 | Wyeth Holdings Corporation | Compositions containing pipercillin and tazobactam useful for injection |
| AU2003230899A1 (en) * | 2003-04-14 | 2004-11-26 | Wyeth Holdings Corporation | Compositions containing piperacillin and tazobactam useful for injection |
| EP1468697B1 (en) * | 2003-04-14 | 2007-12-26 | Wyeth Holdings Corporation | Compositions containing piperacillin and tazobactam useful for injection |
| BRPI0516583A (pt) * | 2004-10-14 | 2008-09-16 | Wyeth Corp | composição farmacêutica e método de tratamento de uma infecção bacteriana |
| ES2284318B1 (es) * | 2005-04-13 | 2008-11-01 | Labiana Development, S.L. | Procedimiento de obtencion de una mezcla en polvo de una sal sodica de piperaciclina y tazobactama, util para su administracion por via inyectable. |
| EP1787641A1 (de) * | 2005-11-22 | 2007-05-23 | Helm AG | Tazobactam-Piperacillin-Lyophilisat |
| US20070286817A1 (en) * | 2006-06-07 | 2007-12-13 | Wyeth | Treating cystic fibrosis with antibiotics via a swirler delivery |
| US20070286818A1 (en) * | 2006-06-07 | 2007-12-13 | Wyeth | Treating cystic fibrosis with antibiotics via an aerosol drug |
| CN1927201B (zh) * | 2006-08-25 | 2011-06-01 | 天津和美生物技术有限公司 | 含哌拉西林的抗生素复方 |
| WO2010017273A2 (en) * | 2008-08-06 | 2010-02-11 | Wyeth | Tigecycline formulations |
| CN103945842A (zh) | 2011-09-09 | 2014-07-23 | 丘比斯特药物股份有限公司 | 治疗肺内感染的方法 |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| ES3026983T3 (en) | 2013-03-15 | 2025-06-12 | Merck Sharp & Dohme Llc | Ceftolozane antibiotic compositions |
| AU2014233637A1 (en) | 2013-09-09 | 2015-03-26 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| CN103550216B (zh) * | 2013-10-30 | 2015-03-11 | 济南康和医药科技有限公司 | 一种哌拉西林钠他唑巴坦钠药物组合物及其制备方法 |
| CA2974282A1 (en) * | 2015-02-23 | 2016-09-01 | Sandoz Ag | Penicillin retard composition for intramuscular injection |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2179348A5 (cg-RX-API-DMAC7.html) | 1972-04-06 | 1973-11-16 | Berthoud Sa | |
| US4452778A (en) | 1980-03-31 | 1984-06-05 | Eli Lilly And Company | Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms |
| CA1209477A (en) | 1981-03-26 | 1986-08-12 | Bruce E. Haeger | Composition of matter comprising a lyophilized preparation of a penicillin derivative |
| US4534977A (en) | 1981-03-26 | 1985-08-13 | American Cyanamid Company | Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin |
| US4477452A (en) | 1981-03-26 | 1984-10-16 | American Cyanamid Company | Composition of matter comprising a lyophilized preparation of a penicillin derivative |
| US4552763A (en) | 1981-12-21 | 1985-11-12 | Eli Lilly And Company | Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms |
| US4594247A (en) | 1981-12-21 | 1986-06-10 | Eli Lilly And Company | Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms |
| US4562073A (en) | 1982-12-24 | 1985-12-31 | Taiho Pharmaceutical Company Limited | Penicillin derivatives |
| US4535078A (en) | 1984-04-06 | 1985-08-13 | The Trustees Of Columbia University In The City Of New York | Antibacterial composition comprising silver sulfadiazine and sodium piperacillin |
| BG46664A1 (en) * | 1985-08-16 | 1990-02-15 | Druzhestven N Izsledovatelski | Method for preparing of 6- /d (-)- alpha- (4- ethyl- 2, 3- dioxo- 1- piperazine carbonylamino)- phenylacetamido/- penicillanic acid |
| IT1213352B (it) | 1986-10-06 | 1989-12-20 | Valleambrosia Di Rozzano Milan | Procedimento per la preparazione dell'acido 6-[d(-)-alfa-(4-etil-2,3-diossipiperazin-1-ilcarbonilamino)-alfa-fenilace tamido]penicillanico e intermedi utili in detto procedimento. |
| FR2690340B1 (fr) * | 1992-04-24 | 1995-02-24 | Scr Newmed | Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant. |
| US5358853A (en) | 1992-08-03 | 1994-10-25 | Akzo Av | Liquid thromboplastin reagent |
| US5763603A (en) | 1993-11-06 | 1998-06-09 | Taiho Pharmaceutical Co., Ltd. | Crystalline tazobactam, and its production and use |
| JPH0859471A (ja) * | 1994-08-25 | 1996-03-05 | Taiho Yakuhin Kogyo Kk | 抗マラリア剤 |
| JPH0867638A (ja) * | 1994-08-31 | 1996-03-12 | Nikken Chem Co Ltd | エリスリトール含有注射剤 |
| US5650421A (en) | 1995-03-31 | 1997-07-22 | Baxter International Inc. | Premixed famotidine formulation |
| JPH1050800A (ja) * | 1996-08-05 | 1998-02-20 | Canon Sales Co Inc | 処理装置 |
| JPH10168091A (ja) * | 1996-12-12 | 1998-06-23 | Ss Pharmaceut Co Ltd | ジアミン白金錯体及びこれを含有する医薬 |
-
1999
- 1999-02-22 US US09/255,513 patent/US6207661B1/en not_active Expired - Lifetime
-
2000
- 2000-01-21 AT AT00906992T patent/ATE426404T1/de active
- 2000-01-21 JP JP2000600646A patent/JP2002537335A/ja not_active Withdrawn
- 2000-01-21 DK DK00906992T patent/DK1154770T3/da active
- 2000-01-21 AU AU28562/00A patent/AU2856200A/en not_active Abandoned
- 2000-01-21 DE DE60041868T patent/DE60041868D1/de not_active Expired - Lifetime
- 2000-01-21 CA CA002361392A patent/CA2361392C/en not_active Expired - Lifetime
- 2000-01-21 EP EP00906992A patent/EP1154770B1/en not_active Expired - Lifetime
- 2000-01-21 PT PT00906992T patent/PT1154770E/pt unknown
- 2000-01-21 ES ES00906992T patent/ES2322790T3/es not_active Expired - Lifetime
- 2000-01-21 WO PCT/US2000/001588 patent/WO2000050035A2/en not_active Ceased
-
2006
- 2006-09-04 JP JP2006239375A patent/JP4820244B2/ja not_active Expired - Lifetime
-
2009
- 2009-04-13 CY CY20091100433T patent/CY1108966T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006316075A5 (cg-RX-API-DMAC7.html) | ||
| JP2002537335A5 (cg-RX-API-DMAC7.html) | ||
| CN105451717B (zh) | 稳定的培美曲塞制剂 | |
| JP2019131596A5 (cg-RX-API-DMAC7.html) | ||
| CN104812392B (zh) | 稳定的培美曲塞制剂 | |
| JP2006516583A5 (cg-RX-API-DMAC7.html) | ||
| JP2012530770A5 (cg-RX-API-DMAC7.html) | ||
| RU2016122609A (ru) | Составы соединений азаиндола | |
| AR098013A2 (es) | UNA COMPOSICIÓN FARMACÉUTICA ACUOSA ESTÉRIL, LISTA PARA SU USO, ADECUADA PARA LA ADMINISTRACIÓN PARENTERAL, MEDIANTE INFUSIÓN PARA EL TRATAMIENTO DE CONDICIONES CARDÍACAS, ENVASADA EN UN RECIPIENTE SELLADO, Y QUE POSEE UN pH ENTRE 3,5 Y 6,5, Y MÉTODO PARA SU FABRICACIÓN | |
| JP2011502968A5 (cg-RX-API-DMAC7.html) | ||
| JP2009545600A5 (cg-RX-API-DMAC7.html) | ||
| RU2007119724A (ru) | Композиции, содержащие эктинэсайдин и дисахарид | |
| RU2009148985A (ru) | Стабилизированные аморфные формы иматиниба мезилата | |
| HRP20100664T1 (hr) | Upotreba 3-(4-amino-1-okso-1,3-dihidroizoindol-2-il)piperidin-2,6-diona u lijecenju limfoma stanica plasta | |
| CA2414063A1 (en) | Highly concentrated stable meloxicam solutions | |
| ECSP088240A (es) | Composición de trazodona para administración una vez por día | |
| JP2019536761A5 (cg-RX-API-DMAC7.html) | ||
| RU2012113844A (ru) | Пероральные суспензионные лекарственные формы ацетата эсликарбазепина | |
| JP2025163108A5 (cg-RX-API-DMAC7.html) | ||
| JP2013505233A5 (cg-RX-API-DMAC7.html) | ||
| JP2011506587A5 (cg-RX-API-DMAC7.html) | ||
| JP2009521473A5 (cg-RX-API-DMAC7.html) | ||
| JP2020502264A (ja) | 抗生物質組成物 | |
| JP2022062153A5 (cg-RX-API-DMAC7.html) | ||
| RU2012112839A (ru) | Новая парентеральная композиция карбамазепина |